User:Ci Mar-Gar/QASC
 | This is not a Wikipedia article: It is an individual user's work-in-progress page, and may be incomplete and/or unreliable. For guidance on developing this draft, see Wikipedia:So you made a userspace draft. Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Quality in Acute Stroke Care (QASC) was a research trial demonstrating that acute stroke patients who received improved management of fever, sugar and swallowing reflects, were 16% more likely to be alive or independent three months after their stroke. The study has generated significant interest amongst stroke research community following its publication in 2011 [1] due to the significant results of the trial, which showed the lowest number needed to treat NNT=6.4, compared to other proven treatments.
BACKGROUND
x THE TRIAL (STUDY DESIGN, RESULTS & CONCLUSION) cluster randomized controlled trial (CRCT)[1]
AFTER THE TRIAL
xx
STUDY INVESTIGATORS
The Trial was led by Prof Sandy Middleton, director of the Nursing Research Institute [2]from the Australian Catholic University
FURTHER READING
Xx
EXTERNAL LINKS
xx
References
- ^ Middleton S, McElduff P, Ward J, Grimshaw JM, Dale S, D'Este C, et al. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. The Lancet. 2011;378 (9804):1699-706.